Adial Pharmaceuticals, Inc.

Ownership Transactions Reported by 10 Insiders

Symbol
ADIL on Nasdaq
Location
1180 Seminole Trail, Suite 495, Charlottesville, VA

There are no Buy or Sell transactions made by insiders since 1/10/2024

Adial Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
William B. Stilley III Director $530K May 23, 2023
Joseph Truluck Chief Financial Officer $111K Mar 25, 2024
Kevin Schuyler Director $2.77K Mar 25, 2024
James W. Newman Jr. Director Mar 25, 2024
Kermit J. Anderson Director Mar 25, 2024
Robertson H. Gilliland Director Mar 25, 2024
Vinay Shah Chief Financial Officer Nov 16, 2024
Tony Goodman Chief Operating Officer, Director Mar 25, 2024
Cary J. Claiborne Chief Executive Officer, Director Dec 5, 2024
Bankole Johnson Director May 23, 2023

Recent Insider Transactions by Companies or Individuals for Adial Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.